Clinical trial
A Placebo Controlled Double-Blind, Parallel Group, Individualizing Dosing Study Optimizing Treatment of Adults With Attention Deficit Hyperactivity Disorder to an Effective Response With OROS Methylphenidate
NCT00937040 is registered in ClinicalTrials.gov with Ortho-McNeil Janssen Scientific Affairs, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo Controlled Double-Blind, Parallel Group, Individualizing Dosing Study Optimizing Treatment of Adults With Attention Deficit Hyperactivity Disorder to an Effective Response With OROS Methylphenidate
- Lead sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- February 28, 2010
- Enrollment
- 357 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.